ExodusPoint Capital Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-12,938
| Closed | -$252K | – | 2161 |
|
|
2023
Q2 | $252K | Buy |
+12,938
| New | +$252K | ﹤0.01% | 1524 |
|
|
2023
Q1 | – | Sell |
-20,199
| Closed | -$590K | – | 2104 |
|
|
2022
Q4 | $590K | Buy |
+20,199
| New | +$590K | 0.01% | 1086 |
|
|
2022
Q3 | – | Sell |
-37,111
| Closed | -$1.65M | – | 2333 |
|
|
2022
Q2 | $1.65M | Buy |
+37,111
| New | +$1.65M | 0.02% | 823 |
|
|
2021
Q2 | – | Sell |
-16,554
| Closed | -$691K | – | 2831 |
|
|
2021
Q1 | $691K | Buy |
16,554
+9,059
| +121% | +$378K | 0.01% | 1096 |
|
|
2020
Q4 | $349K | Buy |
+7,495
| New | +$349K | ﹤0.01% | 1382 |
|